Skip to main content
. 2013 Nov 25;18(2):218–230. doi: 10.1111/jcmm.12153

Fig 9.

Fig 9

Effects of CXCL5/CXCR2 on CXCL8 production. Supernatant levels of CXCL8 proteins produced from HepG2 and HCCLM3 cells stimulated with CXCL5 at 0.1, 1.0 or 10 nM for 24 hrs (A), or treated with vehicle or CXCR2 inhibitor (SB225002) at 0.5, 1.0 or 5.0 μg/ml for 1 hr followed by the stimulation with epidermal growth factor at 100 ng/ml for 24 hrs (B).